Cargando…
Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
The severe acute respiratory syndrome 2 (SARS-CoV-2) has spread rapidly worldwide, not only causing significant morbidity and mortality but also dramatically increasing health care spending. To manage this in Thailand, healthcare workers first received two doses of the CoronaVac vaccine followed by...
Autores principales: | Phumisantiphong, Uraporn, Chunhakan, Sirichan, Manomaipiboon, Anan, Maneerit, Jakravoot, Dechanuwong, Pornchai, Trakarnvanich, Thananda, Oajaum, Wadakorn, Chan-in, Wilawan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940472/ https://www.ncbi.nlm.nih.gov/pubmed/36845212 http://dx.doi.org/10.1016/j.jvacx.2023.100277 |
Ejemplares similares
-
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
Publicado: (2021) -
Impact of ultraviolet germicidal irradiation on new silicone half-piece elastometric respirator (VJR-NMU) performance, structural integrity and sterility during the COVID-19 pandemic
por: Trakarnvanich, Thananda, et al.
Publicado: (2021) -
Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis
por: Manomaipiboon, Anan, et al.
Publicado: (2022) -
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
por: Manomaipiboon, Anan, et al.
Publicado: (2022)